Northern California Rheumatology Society is categorized under Doctors in San Francisco, CA and active since 2010.
Northern California Rheumatology Society was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Barry Shibuya at the company’s single location by writing to 657 Mission St # 603, San Francisco, California CA 94105 or by phoning (615) 467-6411. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Northern California Rheumatology Society |
| Contact Person: | Barry Shibuya |
| Address: | 657 Mission St # 603, San Francisco, California 94105 |
| Phone Number: | (615) 467-6411 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Northern California Rheumatology Society was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Barry Shibuya for inquiries that concern Northern California Rheumatology Society by calling the company number (615) 467-6411, as your correspondence is most welcome. Additionally, the physical location of the single location of Northern California Rheumatology Society can be found at the coordinates 37.786964,-122.400851 as well as the street address 657 Mission St # 603 in San Francisco, California 94105.
For its online presence, you may visit Northern California Rheumatology Society’s website at and engage with its social media outlets through on Twitter and on Facebook.